XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Pay vs Performance Disclosure
pure in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Pay vs Performance Disclosure [Table]      
Pay vs Performance [Table Text Block]
PAY VERSUS PERFORMANCE
In accordance with rules adopted by the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding executive compensation for our principal executive officer (“PEO”) and Non-PEO NEOs and Company performance for the fiscal years listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for any of the years shown.
Year
​ ​
Summary
Compensation
Table Total
for Jack
Khattar(1)
($)
​ ​
Compensation
Actually
Paid to
Jack
Khattar(1)(2)(3)
($)
​ ​
Average
Summary
Compensation
Table Total
for Non-PEO
NEOs(1)
($)
​ ​
Average
Compensation
Actually
Paid to
Non-PEO
NEOs(1)(2)(3)
($)
​ ​
Value of Initial Fixed
$100 Investment
based on:(4)
​ ​
Net
Income
($ Millions)
​ ​
Gross
Product
Sales
($ Millions)(5)
​
​
Total
Shareholder
Return
(“TSR”)
($)
​ ​
Peer
Group
TSR
($)
​
(a)
​ ​
(b)
​ ​
(c)
​ ​
(d)
​ ​
(e)
​ ​
(f)
​ ​
(g)
​ ​
(h)
​ ​
(i)
​
2022
​ ​ ​ ​ 10,012,717 ​ ​ ​ ​ ​ 11,056,323 ​ ​ ​ ​ ​ 1,167,214 ​ ​ ​ ​ ​ 1,433,071 ​ ​ ​ ​ ​ 150.38 ​ ​ ​ ​ ​ 113.65 ​ ​ ​ ​ ​ 61 ​ ​ ​ ​ ​ 1,181 ​ ​
2021
​ ​ ​ ​ 8,116,721 ​ ​ ​ ​ ​ 7,914,950 ​ ​ ​ ​ ​ 979,005 ​ ​ ​ ​ ​ 601,468 ​ ​ ​ ​ ​ 122.93 ​ ​ ​ ​ ​ 126.45 ​ ​ ​ ​ ​ 53 ​ ​ ​ ​ ​ 1,021 ​ ​
2020
​ ​ ​ ​ 6,669,046 ​ ​ ​ ​ ​ 6,134,966 ​ ​ ​ ​ ​ 1,204,624 ​ ​ ​ ​ ​ 939,602 ​ ​ ​ ​ ​ 106.07 ​ ​ ​ ​ ​ 126.42 ​ ​ ​ ​ ​ 127 ​ ​ ​ ​ ​ 951 ​ ​
1.   Jack Khattar was our PEO for each year presented. The individuals comprising the Non-PEO NEOs for each year presented are listed below.
​
2020
​ ​
2021
​ ​
2022
​
​
James P. Kelly1 and Gregory S.
Patrick2
​ ​
Timothy C. Dec3 and James P. Kelly
​ ​
Timothy C. Dec
​
​
Stefan K.F. Schwabe, M.D., Ph.D.
​ ​
Jonathan Rubin, MD
​ ​
Jonathan Rubin, MD
​
​
Padmanabh P. Bhatt, Ph.D.
​ ​
Padmanabh P. Bhatt, Ph.D.
​ ​
Padmanabh P. Bhatt, Ph.D.
​
​
Tami Martin, R.N., Esq.
​ ​
Tami Martin, R.N., Esq.
​ ​
Frank Mottola
​
2.   The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote 3 below.
3.   Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table. Amounts in the Inclusion of Equity Values column are set forth in the table further below.
Year
​ ​
Summary
Compensation Table
Total for Jack
Khattar
($)
​ ​
Exclusion of Stock
Awards and Option
Awards for Jack
Khattar
($)
​ ​
Inclusion of Equity
Values for Jack
Khattar
($)
​ ​
Compensation
Actually Paid
to Jack
Khattar
($)
​
2022
​ ​ ​ ​ 10,012,717 ​ ​ ​ ​ ​ (8,383,750) ​ ​ ​ ​ ​ 9,427,356 ​ ​ ​ ​ ​ 11,056,323 ​ ​
2021
​ ​ ​ ​ 8,116,721 ​ ​ ​ ​ ​ (6,341,179) ​ ​ ​ ​ ​ 6,139,408 ​ ​ ​ ​ ​ 7,914,950 ​ ​
2020
​ ​ ​ ​ 6,669,046 ​ ​ ​ ​ ​ (4,988,696) ​ ​ ​ ​ ​ 4,454,616 ​ ​ ​ ​ ​ 6,134,966 ​ ​
​
1
Mr. Kelly joined the Company as Executive Vice-President and Chief Financial Officer on October 12, 2020 and served in such capacity until August 13, 2021.
​
2
Mr. Patrick, who served as the Company’s Senior Vice President and Chief Financial Officer, retired from the Company effective November 17, 2020, and did not receive a performance bonus for 2020.
​
3
Mr. Dec began serving as our Senior Vice President, Chief Financial Officer as of August 23, 2021.
​
Year
​ ​
Average Summary
Compensation Table
Total for Non-PEO
NEOs
($)
​ ​
Average Exclusion of
Stock Awards and
Option Awards for
Non-PEO NEOs
($)
​ ​
Average Inclusion of
Equity Values for
Non-PEO NEOs
($)
​ ​
Average
Compensation
Actually Paid
to Non-PEO
NEOs
($)
​
2022
​ ​ ​ ​ 1,167,214 ​ ​ ​ ​ ​ (585,346) ​ ​ ​ ​ ​ 851,203 ​ ​ ​ ​ ​ 1,433,071 ​ ​
2021
​ ​ ​ ​ 979,005 ​ ​ ​ ​ ​ (475,728) ​ ​ ​ ​ ​ 98,191 ​ ​ ​ ​ ​ 601,468 ​ ​
2020
​ ​ ​ ​ 1,204,624 ​ ​ ​ ​ ​ (769,998) ​ ​ ​ ​ ​ 504,976 ​ ​ ​ ​ ​ 939,602 ​ ​
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
Year
​ ​
Year-End
Fair Value of
Equity
Awards
Granted
During Year
That
Remained
Unvested as
of Last Day of
Year for Jack
Khattar
($)
​ ​
Change in
Fair Value
from Last Day
of Prior Year
to Last Day of
Year of
Unvested
Equity
Awards for
Jack Khattar
($)
​ ​
Vesting-Date
Fair Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for Jack
Khattar
($)
​ ​
Change in
Fair Value
from Last Day
of Prior Year
to Vesting
Date of
Unvested
Equity
Awards that
Vested During
Year for Jack
Khattar
($)
​ ​
Fair Value at
Last Day of
Prior Year of
Equity
Awards
Forfeited
During Year
for Jack
Khattar
($)
​ ​
Total –
Inclusion
of
Equity
Values
for Jack
Khattar
($)
​
2022
​ ​ ​ ​ 7,084,584 ​ ​ ​ ​ ​ 1,792,665 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 550,107 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 9,427,356 ​ ​
2021
​ ​ ​ ​ 3,805,003 ​ ​ ​ ​ ​ 597,223 ​ ​ ​ ​ ​ 1,053,200 ​ ​ ​ ​ ​ 683,982 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 6,139,408 ​ ​
2020
​ ​ ​ ​ 3,861,800 ​ ​ ​ ​ ​ (156,871) ​ ​ ​ ​ ​ 749,687 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,454,616 ​ ​
Year
​ ​
Average Year-
End Fair
Value of
Equity
Awards
Granted
During Year
That
Remained
Unvested as of
Last Day of
Year for Non-
PEO NEOs
($)
​ ​
Average
Change in
Fair Value
from Last Day
of Prior Year
to Last Day of
Year of
Unvested
Equity
Awards for
Non-PEO
NEOs
($)
​ ​
Average
Vesting-Date
Fair Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for Non-PEO
NEOs
($)
​ ​
Average
Change in
Fair Value
from Last Day
of Prior Year
to Vesting
Date of
Unvested
Equity
Awards that
Vested During
Year for Non-
PEO NEOs
($)
​ ​
Average
Fair
Value at Last
Day of Prior
Year of Equity
Awards
Forfeited
During Year
for Non-PEO
NEOs
($)
​ ​
Total–
Average
Inclusion
of
Equity
Values
for Non-
PEO
NEOs
($)
​
2022
​ ​ ​ ​ 590,102 ​ ​ ​ ​ ​ 218,751 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 42,350 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 851,203 ​ ​
2021
​ ​ ​ ​ 415,633 ​ ​ ​ ​ ​ 25,532 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 26,566 ​ ​ ​ ​ ​ (369,540) ​ ​ ​ ​ ​ 98,191 ​ ​
2020
​ ​ ​ ​ 510,473 ​ ​ ​ ​ ​ (5,497) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 504,976 ​ ​
4.   The Peer Group TSR set forth in this table utilizes the NASDAQ Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended December 31, 2022. The comparison assumes $100 was invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the NASDAQ Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. Cumulative TSR is calculated by dividing (i) the sum of (a) the cumulative amount of any dividends for the measurement period and (b) the change in the company’s share price during the measurement period by (ii) the share price at the beginning of the measurement period. This assumes dividend reinvestment.
5.   We determined Gross Product Sales to be the most important financial performance measure used to link Company performance to Compensation Actually Paid to our PEO and Non-PEO NEOs in 2022. This performance measure may not have been the most important financial performance measure for years 2021 and 2020 and we may determine a different financial performance measure to be the most important financial performance measure in future years.
   
Company Selected Measure Name Gross Product Sales    
Named Executive Officers, Footnote [Text Block]
1.   Jack Khattar was our PEO for each year presented. The individuals comprising the Non-PEO NEOs for each year presented are listed below.
​
2020
​ ​
2021
​ ​
2022
​
​
James P. Kelly1 and Gregory S.
Patrick2
​ ​
Timothy C. Dec3 and James P. Kelly
​ ​
Timothy C. Dec
​
​
Stefan K.F. Schwabe, M.D., Ph.D.
​ ​
Jonathan Rubin, MD
​ ​
Jonathan Rubin, MD
​
​
Padmanabh P. Bhatt, Ph.D.
​ ​
Padmanabh P. Bhatt, Ph.D.
​ ​
Padmanabh P. Bhatt, Ph.D.
​
​
Tami Martin, R.N., Esq.
​ ​
Tami Martin, R.N., Esq.
​ ​
Frank Mottola
​
1
Mr. Kelly joined the Company as Executive Vice-President and Chief Financial Officer on October 12, 2020 and served in such capacity until August 13, 2021.
​
2
Mr. Patrick, who served as the Company’s Senior Vice President and Chief Financial Officer, retired from the Company effective November 17, 2020, and did not receive a performance bonus for 2020.
​
3
Mr. Dec began serving as our Senior Vice President, Chief Financial Officer as of August 23, 2021.
​
    
Peer Group Issuers, Footnote [Text Block]
4.   The Peer Group TSR set forth in this table utilizes the NASDAQ Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation S-K included in our Annual Report for the year ended December 31, 2022. The comparison assumes $100 was invested for the period starting December 31, 2019, through the end of the listed year in the Company and in the NASDAQ Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance. Cumulative TSR is calculated by dividing (i) the sum of (a) the cumulative amount of any dividends for the measurement period and (b) the change in the company’s share price during the measurement period by (ii) the share price at the beginning of the measurement period. This assumes dividend reinvestment.
   
PEO Total Compensation Amount $ 10,012,717 $ 8,116,721 $ 6,669,046
PEO Actually Paid Compensation Amount $ 11,056,323 7,914,950 6,134,966
Adjustment To PEO Compensation, Footnote [Text Block]
3.   Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table. Amounts in the Inclusion of Equity Values column are set forth in the table further below.
Year
​ ​
Summary
Compensation Table
Total for Jack
Khattar
($)
​ ​
Exclusion of Stock
Awards and Option
Awards for Jack
Khattar
($)
​ ​
Inclusion of Equity
Values for Jack
Khattar
($)
​ ​
Compensation
Actually Paid
to Jack
Khattar
($)
​
2022
​ ​ ​ ​ 10,012,717 ​ ​ ​ ​ ​ (8,383,750) ​ ​ ​ ​ ​ 9,427,356 ​ ​ ​ ​ ​ 11,056,323 ​ ​
2021
​ ​ ​ ​ 8,116,721 ​ ​ ​ ​ ​ (6,341,179) ​ ​ ​ ​ ​ 6,139,408 ​ ​ ​ ​ ​ 7,914,950 ​ ​
2020
​ ​ ​ ​ 6,669,046 ​ ​ ​ ​ ​ (4,988,696) ​ ​ ​ ​ ​ 4,454,616 ​ ​ ​ ​ ​ 6,134,966 ​ ​
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
Year
​ ​
Year-End
Fair Value of
Equity
Awards
Granted
During Year
That
Remained
Unvested as
of Last Day of
Year for Jack
Khattar
($)
​ ​
Change in
Fair Value
from Last Day
of Prior Year
to Last Day of
Year of
Unvested
Equity
Awards for
Jack Khattar
($)
​ ​
Vesting-Date
Fair Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for Jack
Khattar
($)
​ ​
Change in
Fair Value
from Last Day
of Prior Year
to Vesting
Date of
Unvested
Equity
Awards that
Vested During
Year for Jack
Khattar
($)
​ ​
Fair Value at
Last Day of
Prior Year of
Equity
Awards
Forfeited
During Year
for Jack
Khattar
($)
​ ​
Total –
Inclusion
of
Equity
Values
for Jack
Khattar
($)
​
2022
​ ​ ​ ​ 7,084,584 ​ ​ ​ ​ ​ 1,792,665 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 550,107 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 9,427,356 ​ ​
2021
​ ​ ​ ​ 3,805,003 ​ ​ ​ ​ ​ 597,223 ​ ​ ​ ​ ​ 1,053,200 ​ ​ ​ ​ ​ 683,982 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 6,139,408 ​ ​
2020
​ ​ ​ ​ 3,861,800 ​ ​ ​ ​ ​ (156,871) ​ ​ ​ ​ ​ 749,687 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,454,616 ​ ​
   
Non-PEO NEO Average Total Compensation Amount $ 1,167,214 979,005 1,204,624
Non-PEO NEO Average Compensation Actually Paid Amount $ 1,433,071 601,468 939,602
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
3.   Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards and Option Awards column are the totals from the Stock Awards and Option Awards columns set forth in the Summary Compensation Table. Amounts in the Inclusion of Equity Values column are set forth in the table further below.
Year
​ ​
Average Summary
Compensation Table
Total for Non-PEO
NEOs
($)
​ ​
Average Exclusion of
Stock Awards and
Option Awards for
Non-PEO NEOs
($)
​ ​
Average Inclusion of
Equity Values for
Non-PEO NEOs
($)
​ ​
Average
Compensation
Actually Paid
to Non-PEO
NEOs
($)
​
2022
​ ​ ​ ​ 1,167,214 ​ ​ ​ ​ ​ (585,346) ​ ​ ​ ​ ​ 851,203 ​ ​ ​ ​ ​ 1,433,071 ​ ​
2021
​ ​ ​ ​ 979,005 ​ ​ ​ ​ ​ (475,728) ​ ​ ​ ​ ​ 98,191 ​ ​ ​ ​ ​ 601,468 ​ ​
2020
​ ​ ​ ​ 1,204,624 ​ ​ ​ ​ ​ (769,998) ​ ​ ​ ​ ​ 504,976 ​ ​ ​ ​ ​ 939,602 ​ ​
Year
​ ​
Average Year-
End Fair
Value of
Equity
Awards
Granted
During Year
That
Remained
Unvested as of
Last Day of
Year for Non-
PEO NEOs
($)
​ ​
Average
Change in
Fair Value
from Last Day
of Prior Year
to Last Day of
Year of
Unvested
Equity
Awards for
Non-PEO
NEOs
($)
​ ​
Average
Vesting-Date
Fair Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for Non-PEO
NEOs
($)
​ ​
Average
Change in
Fair Value
from Last Day
of Prior Year
to Vesting
Date of
Unvested
Equity
Awards that
Vested During
Year for Non-
PEO NEOs
($)
​ ​
Average
Fair
Value at Last
Day of Prior
Year of Equity
Awards
Forfeited
During Year
for Non-PEO
NEOs
($)
​ ​
Total–
Average
Inclusion
of
Equity
Values
for Non-
PEO
NEOs
($)
​
2022
​ ​ ​ ​ 590,102 ​ ​ ​ ​ ​ 218,751 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 42,350 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 851,203 ​ ​
2021
​ ​ ​ ​ 415,633 ​ ​ ​ ​ ​ 25,532 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 26,566 ​ ​ ​ ​ ​ (369,540) ​ ​ ​ ​ ​ 98,191 ​ ​
2020
​ ​ ​ ​ 510,473 ​ ​ ​ ​ ​ (5,497) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 504,976 ​ ​
   
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Description of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Company Total Shareholder Return
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and the Company’s cumulative TSR over the three most recently completed fiscal years.
[MISSING IMAGE: bc_companytsr-4c.jpg]
   
Compensation Actually Paid vs. Net Income [Text Block]
Description of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Net Income
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and our Net Income during the three most recently completed fiscal years.
[MISSING IMAGE: bc_netincome-4c.jpg]
Net Income included in the preceding chart is calculated in accordance with GAAP (Generally Accepted Accounting Principles). During 2020, 2021 and 2022, the Company accrued amortization expenses for intangible assets of $15.7 million, $30.0 million and $82.6 million, respectively. Amortization of intangible assets increased during 2021 and 2022 primarily due to the amortization of definitive-lived intangible assets acquired in the Adamas and US WorldMeds acquisitions.
   
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Description of Relationship Between PEO and Non-PEO NEO Compensation Actually Paid and Gross Product Sales
The following chart sets forth the relationship between Compensation Actually Paid to our PEO, the average of Compensation Actually Paid to our Non-PEO NEOs, and our Gross Product Sales during the three most recently completed fiscal years.
[MISSING IMAGE: bc_productsales-4c.jpg]
   
Total Shareholder Return Vs Peer Group [Text Block]
Description of Relationship Between Company TSR and Peer Group TSR
The following chart compares our cumulative TSR over the three most recently completed fiscal years to that of the NASDAQ Biotechnology Index over the same period.
[MISSING IMAGE: bc_nasdaqbiotech-4c.jpg]
   
Tabular List [Table Text Block]
Tabular List of Most Important Financial Performance Measures
The following table presents the financial performance measures that the Company considers to have been the most important in linking Compensation Actually Paid to our PEO and other NEOs for 2022 to Company performance. The measures in this table are not ranked.
​ ​
Gross Product Sales
Operating Income
​ ​
​ ​ ​ ​ ​
   
Total Shareholder Return Amount $ 150.38 122.93 106.07
Peer Group Total Shareholder Return Amount 113.65 126.45 126.42
Net Income (Loss) $ 61,000,000 $ 53,000,000 $ 127,000,000
Company Selected Measure Amount 1,181 1,021 951
PEO Name Jack Khattar    
Measure [Axis]: 1      
Pay vs Performance Disclosure [Table]      
Measure Name Gross Product Sales    
Non-GAAP Measure Description [Text Block]
5.   We determined Gross Product Sales to be the most important financial performance measure used to link Company performance to Compensation Actually Paid to our PEO and Non-PEO NEOs in 2022. This performance measure may not have been the most important financial performance measure for years 2021 and 2020 and we may determine a different financial performance measure to be the most important financial performance measure in future years.
   
Measure [Axis]: 2      
Pay vs Performance Disclosure [Table]      
Measure Name Operating Income    
PEO [Member] | Equity Awards Value In Summary Compensation Table [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ (8,383,750) $ (6,341,179) $ (4,988,696)
PEO [Member] | Total Equity Awards Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 9,427,356 6,139,408 4,454,616
PEO [Member] | Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 7,084,584 3,805,003 3,861,800
PEO [Member] | Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 1,792,665 597,223 (156,871)
PEO [Member] | Change In Fair Value As Of Vesting Date Of Awards Vested During Current Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount   1,053,200 749,687
PEO [Member] | Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 550,107 683,982  
Non-PEO NEO [Member] | Equity Awards Value In Summary Compensation Table [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (585,346) (475,728) (769,998)
Non-PEO NEO [Member] | Total Equity Awards Adjustments [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 851,203 98,191 504,976
Non-PEO NEO [Member] | Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 590,102 415,633 510,473
Non-PEO NEO [Member] | Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 218,751 25,532 $ (5,497)
Non-PEO NEO [Member] | Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ 42,350 26,566  
Non-PEO NEO [Member] | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount   $ (369,540)